OBJECTIVE -To systematically evaluate the association between serum uric acid (SUA) level and subsequent development of type 2 diabetes.
I
dentifying risk factors for the development of type 2 diabetes is essential for its early screening and prevention. Serum uric acid (SUA) level has been suggested to be associated with risk of type 2 diabetes. Biologically, uric acid (UA) plays an important role in worsening of insulin resistance in animal models by inhibiting the bioavailability of nitric oxide, which is essential for insulin-stimulated glucose uptake (1) . However, hyperinsulinemia as a consequence of insulin resistance causes an increase in SUA concentration by both reducing renal UA secretion (2) and accumulating substrates for UA production (3) . Therefore, it remains controversial whether SUA is independently associated with the development of type 2 diabetes. The aim of our meta-analysis was to summarize the association between SUA level and risk of type 2 diabetes derived from previously published cohort studies and to examine the effect of study characteristics on this association.
RESEARCH DESIGN AND METHODS

Search strategy
The meta-analysis was fundamentally conducted according to the checklist of the Meta-analysis of Observational Studies in Epidemiology (4 Included reports had to meet the following criteria: 1) prospective or historical cohort study, 2) inclusion of type 2 diabetes as a specified outcome, 3) baseline assessment of SUA level, and 4) inclusion of data on relative risk (RR), which is generally expressed as the odds ratio in a historical cohort study or the risk ratio in a prospective cohort study, and its corresponding 95% CIs (or data to calculate them) for type 2 diabetes associated with SUA level. When two or more studies were conducted using the same subjects, the study that included the most recently updated data was selected.
Data abstraction
The data that we abstracted included the first author's name, year of publication, country of origin, cohort design (i.e., prospective or historical cohort), methods for ascertaining diabetes, mean follow-up duration, mean or midpoint of participants' age, proportion of men, baseline SUA level, number of participants and events, and adjusted variables. Odds and risk ratios were combined as indicators of RR, based on the assumption that the odds ratio is an approximation of the risk ratio; this assumption has some limitations, however, especially when the outcome of interest is common (5).
If a study provided several RRs, such as unadjusted and adjusted RRs, the most completely adjusted RR was used. Each RR was transformed to its natural logarithm (log RR), and its corresponding 95% CI or P value was used to calculate the SE for each log RR. Two of our investigators independently reviewed each published article and extracted the relevant information. Any disagreement was resolved by consensus.
Data synthesis
To quantify the dose-response relationship between the baseline SUA level and risk of type 2 diabetes, we calculated the RR for each 1 mg/dl increase in SUA in each study. For studies that analyzed SUA level not as a continuous but as a categorical variable (i.e., studies where subjects were categorized based on SUA level and RRs for the development of type 2 diabetes according to SUA level were reported), we used the method for trend estimation supported by Berlin et al. (6) and Orsini et al. (7) . This method is particularly useful when the full data are not available. It enables us to correct for covariance between risk estimates from the same study and to estimate the corrected linear trend using generalized least squares if data on the adjusted RR and the number of participants (or person-time) and cases for each category are provided.
When the mean SUA level was not reported, the range's midpoint in each category was used, except for the lowest and highest category, for which the mean SUA level was estimated by assuming normality of SUA distribution, which is the same method as used in a previously published meta-analysis (8) . Each log RR was pooled by using a random-effects model (9) . The overall RR and its 95% CI could be calculated by exponentiation of the pooled log RR. We assessed heterogeneity of RRs across studies using both I 2 and Q statistics (10) .
Sensitivity analyses
The studies included were stratified by key factors related to cohort design (i.e., prospective or historical cohort) and other study properties related to study quality and participant characteristics that were identified a priori. Study quality was assessed according to the method of ascertainment of diabetes (whether blood measurements, or reports by participants or physicians, or both), mean follow-up duration (Ͼ8 or Յ8 years), and inclusion of adjustment for the following potentially important confounding variables: alcohol intake (yes or no) and metabolic profile (sufficient or insufficient). We regarded the adjustment for metabolic variables as sufficient when the risk estimate was adjusted for more than three factors among obesity, hypertension (or systolic blood pressure), fasting plasma glucose, HDL cholesterol, and triglycerides. We identified country of origin (Asian or Western countries), mean age (Ͼ50 or Յ50 years), sex (whether men only, women only, or both men and women), and mean SUA level (Ͼ5.5 or Յ5.5 mg/ dl) as possible participant characteristics. We calculated the pooled RR within the strata of each study characteristic, and meta-regression analyses were conducted to assess the effects of these study characteristics on the type 2 diabetes risk and incremental increase in SUA level.
The possibility of publication bias was assessed by the Begg's and the Egger's tests (11, 12) and visual inspection of a funnel plot. We also performed the Duval and Tweedie "trim-and-fill" procedure (13) to further assess the possible effect of publication bias in our meta-analysis. This method considers the possibility of hypothetical "missing" studies that might exist, imputes their RRs, and recalculates a pooled RR that incorporates the hypothetical missing studies as though they actually existed. Data were analyzed by using STATA software (version 10; Stata, College Station, TX). P Ͻ 0.05 was considered as statistically significant except for the test of publication bias, in which the level of significance is P Ͻ 0.10 (14). (17, 20) used reports by participants and/or physicians only, and five (15, 16, 21, 23, 24) used both. Risk measures were adjusted for alcohol intake in five studies (17, 19, 20, 22, 24) , and the adjustment for sufficient metabolic variables was sufficient in five studies (18, (21) (22) (23) (24) . A few risk estimates were adjusted for smoking status (three studies) (17, 19, 20) , family history of diabetes (four studies) (16, 20, 22, 24) , and fasting insulin concentration (three studies) (18, 21, 24) . Only two studies (21, 24) considered the effect of serum creatinine, and one study (25) considered the effect of diuretic use. None of risk measurements was adjusted for other drugs that influence SUA level such as alloprinol. Figure 1 shows a forest plot with RRs and 95% CIs and pooled estimates for the reduction in risk of type 2 diabetes for each Table 2 shows findings of the stratified and meta-regression analysis to explore the effects of study characteristic. An increased risk of type 2 diabetes associated with an incremental increase in SUA was consistently found within all strata of each study characteristic (i.e., all pooled RRs were Ͼ1). There were no significant differences in the pooled risk estimates between cohort design (pooled RR [95% CI] of 1.22 [1.10 -1.36] for historical cohort and 1.10 [1.01-1.20] for prospective cohort, P ϭ 0.36). The influence of participant characteristics on the study results was not significant. Adjustment for alcohol intake attenuated the association between SUA and type 2 diabetes risk (P ϭ 0.02), whereas the effect of sufficient adjustment for metabolic variables was not significant (P ϭ 0.46).
RESULTS
Literature search
Overall and stratified analyses
Test of publication bias
Visual inspection of the funnel plot revealed asymmetry (see online appendix A [available at http://care.diabetesjournals. org/cgi/content/full/dc09-0288/DC1]). This raises the possibility of publication bias, which was statistically supported by the Egger's test (P ϭ 0.06). We decided to adjust for this publication bias using the trim-and-fill method (13) . According to this method, it was suggested that there were three hypothetical negative unpublished cohorts that distorted the symmetry of the funnel plot. When these cohorts were incorporated to produce a hypothetically symmetrical funnel plot, the association between SUA and type 2 diabetes was modestly attenuated (RR 1.10 [95% CI 1.03-1.20]) but remained statistically significant (P ϭ 0.009).
CONCLUSIONS -Our meta-analysis is the first to summarize the quantitative relationship between SUA level and risk of type 2 diabetes, indicating that each 1 mg/dl increase in SUA resulted in a 17% increase in the risk of type 2 diabetes. Table 3 compares other risk factors of type 2 diabetes, established from metaanalysis or systematic review (26 -29) , with SUA. Interestingly, the effect of a 1 mg/dl increment in SUA has been found to be comparable to a 1 kg/m 2 increment in BMI.
Pathologically and epidemiologically, it has been indicated that elevated SUA concentration is correlated with lifestyle factors (high alcohol intake [30] in particular) and various metabolic profiles (especially high values of BMI, blood pressure, fasting plasma glucose and triglycerides, and low HDL cholesterol values [31, 32] , which are typically considered to be diagnostic criteria for metabolic syndrome [33] ). Therefore, it is possible to establish whether the observed positive association between SUA level and risk of type 2 diabetes is noncausal. Our sensitivity analysis indicated that a significant association was observed if analyses were limited to studies that included adjustment for alcohol intake or sufficient metabolic confounders (i.e., more than three metabolic confounders among BMI, fasting plasma glucose, hypertension [or systolic blood pressure], HDL cholesterol, and triglycerides), although the adjustment weakened the association. Therefore, the results of this analysis strongly suggest that SUA is an independent predictor of the development of type 2 diabetes. Therefore, these findings suggest that there are both noncausal and causal associations between SUA level and the risk of type 2 diabetes.
The limitations of this meta-analysis must be considered. First, the overall effect estimated by the current analysis might be inaccurate due to the statistically significant publication bias. According to the results of the compensatory trim-andfill method, the overall RR of type 2 diabetes for each 1 mg/dl SUA increase should be scaled downward by 0.07 to *Pooled RRs of type 2 diabetes for each 1 mg/dl increase in SUA within the strata of each study characteristic are indicated. †Represents the test for significance of the effect across strata. ‡If the RRs were adjusted for more than three confounders (among BMI, fasting plasma glucose, hypertension ͓or systolic blood pressure͔, HDL cholesterol, and triglycerides), they were regarded as sufficient; otherwise, they were regarded as insufficient.
adjust for publication bias. However, this method may overestimate the magnitude of any publication bias (34) . Moreover, this method did not change the statistical significance of the association between SUA level and development of type 2 diabetes. Therefore, the effect of adjustment for publication bias was probably modest. Second, the odds and risk ratios were combined as indicators of RR. The odds ratio overestimates the risk ratio, especially when the outcome of interest is common. It is possible that this method could distort the overall and stratified analyses within cohort design. The overestimation is, however, of little practical importance and can be ignored as long as the pooled risk ratio is near to 1 and the total incidence is relatively rare (Ͻ10%), as they were in our meta-analysis (5). Third, in the sensitivity analysis, the statistical power might be insufficient to explain the source of the large study heterogeneity because of the small number of data units within strata. For example, there was a substantially larger increase in the risk of elevated SUA for development of type 2 diabetes observed in Western countries (RR 1.27) compared with Asian countries (RR 1.09) and for women (RR 1.28) compared with men (RR 1.09). Although these differences were statistically insignificant, we cannot exclude the possibility of the influence of race or sex on the association between SUA level and type 2 diabetes. This issue might be solved by a patient-level metaanalysis, which would be beyond the current meta-analysis. Fourth, there were few studies that included a consideration of significant confounders influencing SUA level, such as serum creatinine and drugs (e.g., diuretic agents or alloprinol). These confounders could contribute to modification of the association between SUA and risk of type 2 diabetes. Fifth, we thought it was too early to determine whether there is a cutoff level in SUA to increase or reduce the risk of development of type 2 diabetes because of both the limited number of studies that used SUA level as a categorical variable and provided RR data for each category and the variation in methods of how SUA levels in each subject were categorized. Therefore, we cannot rule out the possibility that SUA level has a threshold effect on the risk of type 2 diabetes rather than a doseresponse effect.
In conclusion, our meta-analysis suggests that SUA level is independently associated with the development of type 2 diabetes. It is possible that these findings are the first step to utilizing SUA, which has been suggested to be a risk factor for type 2 diabetes, in primary care medical practice. Further research should attempt to investigate whether SUA would be useful for predicting type 2 diabetes with respect to the prevention of type 2 diabetes; for example, studies should aim to specify the population for which the SUA level is especially important and to determine the SUA threshold for increased risk of type 2 diabetes. 
